Chenodeoxycholic acid therapy in erythrohepatic protoporphyria. 1986

J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson

The short-term effect of chenodeoxycholic acid administration on the excretion of protoporphyrin was investigated in 5 patients suffering from erythrohepatic protoporphyria. Faeces were collected for 7 days, 10 ml of bile was sampled daily and blood was drawn every 2 to 3 days. Chenodeoxycholic acid was given in a dosage of 15 mg/kg/day from the 8th day. Collection of faeces, bile and blood was then continued for 10 more days. Protoporphyrin concentration was measured by high-pressure liquid chromatography and fluorometry. Following the administration of chenodeoxycholic acid the concentration of protoporphyrin in faeces and bile decreased significantly. In addition, all patients showed a significant decrease in erythrocyte protoporphyrin concentration. These results indicate that chenodeoxycholic acid therapy causes a marked decrease in the excretion of protoporphyrin in patients with erythrohepatic protoporphyria. The subsequent decrease in erythrocyte protoporphyrin suggests that chenodeoxycholic acid inhibits the production of protoporphyrin in the liver.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D011164 Porphyrias A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. Porphyria,Porphyrin Disorder,Disorder, Porphyrin,Disorders, Porphyrin,Porphyrin Disorders
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D011524 Protoporphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.
D002635 Chenodeoxycholic Acid A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones. Chenic Acid,Chenodeoxycholate,Chenodiol,Gallodesoxycholic Acid,Chenique Acid,Chenix,Chenofalk,Chenophalk,Henohol,Quenobilan,Quenocol,Sodium Chenodeoxycholate,Acid, Chenic,Acid, Chenique,Acid, Chenodeoxycholic,Acid, Gallodesoxycholic,Chenodeoxycholate, Sodium
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
January 1988, Dermatologische Monatschrift,
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
June 1972, California medicine,
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
July 1985, Der Internist,
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
January 1986, Patologia polska,
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
October 1983, Deutsche medizinische Wochenschrift (1946),
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
July 1985, Der Internist,
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
July 1992, Deutsche medizinische Wochenschrift (1946),
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
August 1978, Annals of clinical research,
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
November 1989, Deutsche medizinische Wochenschrift (1946),
J Van Hattum, and H Baart de la Faille, and J W Van den Berg, and A Edixhoven-Bosdijk, and J H Wilson
January 1974, Acta dermato-venereologica,
Copied contents to your clipboard!